-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk: The European Medicines Agency's Human Medicines Products Committee recommended that the European Union approve Frehemgo®, the first coagulation factor VIII analog drug that can be administered monthly.

Zhitongcaijing·09/17/2026 14:17:09
Listen to the news
Novo Nordisk: The European Medicines Agency's Human Medicines Products Committee recommended that the European Union approve Frehemgo®, the first coagulation factor VIII analog drug that can be administered monthly.